NYSE:CBT - Cabot Stock Price, Forecast & News

Cabot's stock was trading at $29.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CBT stock has decreased by 16.3% and is now trading at $25.04. View which stocks have been mosted impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cabot.

Cabot is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for Cabot.

Cabot Corp (NYSE:CBT) released its earnings results on Monday, February, 3rd. The specialty chemicals company reported $0.69 EPS for the quarter, missing the consensus estimate of $0.73 by $0.04. The specialty chemicals company earned $727 million during the quarter, compared to analysts' expectations of $772.38 million. Cabot had a net margin of 3.98% and a return on equity of 18.47%. The business's revenue was down 11.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.87 EPS. View Cabot's earnings history.

Cabot declared a quarterly dividend on Friday, January 10th. Investors of record on Friday, February 28th will be given a dividend of $0.35 per share on Friday, March 13th. This represents a $1.40 annualized dividend and a dividend yield of 5.59%. The ex-dividend date is Thursday, February 27th. View Cabot's dividend history.

Cabot declared that its Board of Directors has authorized a stock buyback program on Monday, July 16th 2018, which authorizes the company to repurchase $400,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 10.3% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's board believes its stock is undervalued.

Cabot issued an update on its FY20 earnings guidance on Monday, February, 3rd. The company provided EPS guidance of $3.60-3.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.80.

7 equities research analysts have issued 1 year price targets for Cabot's shares. Their forecasts range from $31.00 to $52.00. On average, they expect Cabot's stock price to reach $43.00 in the next year. This suggests a possible upside of 71.7% from the stock's current price. View analysts' price targets for Cabot.

Media headlines about CBT stock have been trending negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cabot earned a news impact score of -2.1 on InfoTrie's scale. They also gave news coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutCabot.

Cabot saw a decrease in short interest in the month of February. As of February 14th, there was short interest totaling 804,200 shares, a decrease of 10.5% from the January 30th total of 898,400 shares. Based on an average daily trading volume, of 289,000 shares, the days-to-cover ratio is presently 2.8 days. Approximately 1.5% of the shares of the company are sold short. View Cabot's Current Options Chain.

Some companies that are related to Cabot include LyondellBasell Industries (LYB), Clarivate Analytics (CCC), Westlake Chemical (WLK), Kronos Worldwide (KRO), Tredegar (TG), Hawkins (HWKN), Koppers (KOP) and Trecora Resources (TREC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Energy Transfer LP Unit (ET), Broadcom (AVGO), AT&T (T), Pfizer (PFE), Intel (INTC), Ford Motor (F), The Coca-Cola (KO), Verizon Communications (VZ), Cisco Systems (CSCO) and Gilead Sciences (GILD).

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot's stock is owned by a number of institutional and retail investors. Top institutional shareholders include LSV Asset Management (4.94%), Earnest Partners LLC (4.63%), Bank of New York Mellon Corp (4.22%), Victory Capital Management Inc. (2.59%), State Street Corp (2.58%) and Victory Capital Management Inc. (2.57%). Company insiders that own Cabot stock include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View institutional ownership trends for Cabot.

CBT stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bank of New York Mellon Corp, State Street Corp, Bank of America Corp DE, Los Angeles Capital Management & Equity Research Inc., Loomis Sayles & Co. L P, Credit Suisse AG, and Goldman Sachs Group Inc.. View insider buying and selling activity for Cabot.

CBT stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Victory Capital Management Inc., Victory Capital Management Inc., Earnest Partners LLC, AJO LP, Renaissance Technologies LLC, Man Group plc, and Nuveen Asset Management LLC. View insider buying and selling activity for Cabot.

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CBT stock can currently be purchased for approximately $25.04.

Cabot has a market capitalization of $1.42 billion and generates $3.34 billion in revenue each year. The specialty chemicals company earns $157 million in net income (profit) each year or $3.91 on an earnings per share basis. Cabot employs 4,500 workers across the globe. View additional information about Cabot.

The official website for Cabot is http://www.cabot-corp.com/.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected]